KTTA logo
KTTA NASDAQ US

Pasithea Therapeutics Corp. - Common Stock

Healthcare · Biotechnology Website · IPO Aug 2021
$0.77
▲ +$0.03 (+3.49%)
Vol 293K
3
Quality Score
fail
Mkt Cap
$29.8M
ROE
-97.9%
Margin
-6478.4%
D/E
0.00
Beta
0.18
52W
$0–$4

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

ALLR
Allarity Therapeutics Inc
$17.3M
OTLK
Outlook Therapeutics Inc
$101.3M
LTRN
Lantern Pharma Inc
$33.9M
TVGN
Tevogen Bio Holdings Inc
$65.8M
BIAF
bioAffinity Technologies Inc
$5.3M
MDCX
Medicus Pharma Ltd
$38.4M
CUE
Cue Biopharma Inc
$27.9M
APLM
Apollomics Inc
$20.6M

Earnings

Beat rate: 25.0%
Next Report May 13, 2026
EPS Estimate: $-0.46
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.46 — —
Dec 2025 $-0.18 $-0.79 $-0.61
Dec 2024 — $-2.41 —
Mar 2022 $-0.41 $-1.40 $-0.99

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -88.6% -88.1% -88.6% -88.6% -88.6% -97.9%
P/E (TTM) — — — — — —
Net Margin — -6478.4% -6478.4% -6478.4% -6478.4% -6478.4%
Gross Margin — 100.5% 100.5% 100.5% 100.5% 100.5%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 4.97 3.84 4.97 4.97 4.97 4.02

Key Ratios

ROA (TTM)
-88.0%
P/S (TTM)
26.84
P/B
0.3
EPS (TTM)
$-5.21
CF/Share
$-0.60
52W High
$3.85
52W Low
$0.28
$0.28 52-Week Range $3.85

How does KTTA compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

KTTA AAPG ABEO ABOS ABP

KTTA valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
26.8
▲ 109% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
0.3
▼ 89% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

KTTA profitability vs Biotechnology peers

ROE
-97.9%
▼ 45% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-6478.4%
▼ 2159% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
100.5%
▲ 28% above peers (78.6%)
vs Peers
vs Industry
Below avg
ROA
-88.0%
▼ 88% below peers (-46.7%)
vs Peers
vs Industry
Weak

KTTA financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
4.0
▼ 10% below peers (4.4)
vs Peers
vs Industry
In line
Beta
0.2
▼ 81% below peers (1.0)
vs Peers
vs Industry
More volatile

KTTA fundamentals radar

KTTA Peer median Industry

KTTA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

KTTA vs peers: key metrics

Latest News

No related news yet